Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers

Jun 18, 2026 - 16:00
 0  0
Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers
The FDA issued a LHCP to notify providers that Stereotactic Breast Biopsy Needles (product code KNW) are experiencing a supply disruption.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0